| 000 | 01539 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517104813.0 | ||
| 264 | 0 | _c20160927 | |
| 008 | 201609s 0 0 rus d | ||
| 022 | _a0869-2092 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKundashev, U K | |
| 245 | 0 | 0 |
_a[EFFECT OF MEDIATOR-TYPE DRUGS ON HUMAN PSYCHOPHYSIOLOGICAL STATUS DURING MODEL OPERATOR ACTIVITY]. _h[electronic resource] |
| 260 |
_bEksperimental'naia i klinicheskaia farmakologiia _c2016 |
||
| 300 |
_a9-13 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnabasine _xpharmacology |
| 650 | 0 | 4 |
_aAttention _xdrug effects |
| 650 | 0 | 4 |
_aBelladonna Alkaloids _xpharmacology |
| 650 | 0 | 4 |
_aBenzodiazepines _xpharmacology |
| 650 | 0 | 4 |
_aCentral Nervous System Stimulants _xpharmacology |
| 650 | 0 | 4 |
_aDioxanes _xpharmacology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aHaloperidol _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoproterenol _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 | _aPsychophysiology |
| 650 | 0 | 4 |
_aSydnones _xpharmacology |
| 650 | 0 | 4 | _aTask Performance and Analysis |
| 650 | 0 | 4 |
_aTranquilizing Agents _xpharmacology |
| 650 | 0 | 4 |
_aValproic Acid _xpharmacology |
| 650 | 0 | 4 |
_aYohimbine _xpharmacology |
| 700 | 1 | _aSalenko, Yu A | |
| 700 | 1 | _aMorozov, I S | |
| 700 | 1 | _aZurdinov, A Z | |
| 700 | 1 | _aBarchukov, V G | |
| 773 | 0 |
_tEksperimental'naia i klinicheskaia farmakologiia _gvol. 79 _gno. 2 _gp. 9-13 |
|
| 999 |
_c26228008 _d26228008 |
||